The Great Unbalding. Fallen Follicles, Rise! (NY Mag)
Scientists at Pelage Pharmaceuticals unveiled PP405, a novel drug that reprograms dormant hair‑follicle stem cells to regrow thick hair on balding scalp. Early Phase 2a data released in June 2024 showed rapid regrowth in areas previously considered irreversibly lost, sparking intense excitement on the Tressless subreddit. Existing FDA‑approved treatments like minoxidil and finasteride only preserve existing hair and carry side‑effects, leaving a large unmet need. PP405 could represent the first therapy to truly reverse androgenetic alopecia.
New Study Published Evaluating PharmaSens All-in-One Insulin Patch Pump
PharmaSens AG announced that the Journal of Diabetes Science and Technology published data from the first clinical feasibility study of its niia all‑in‑one insulin patch pump, which combines insulin delivery with continuous glucose monitoring. The single‑arm trial enrolled 18 adults...
Planning AHPRA Registration? English Requirements Change From 23 April 2026
AHPRA will tighten English language standards for registration starting 23 April 2026. While overall IELTS/PEL scores and the Listening and Reading components are being lowered, the Speaking component is being raised across all accepted tests. Applicants must now demonstrate stronger oral communication...
New Tool Launches to Support Women Through Post-Loss Journey
Carea has introduced a free "Healing After Loss" mode within its pregnancy and postnatal wellbeing app, offering on‑demand mental‑health tools, expert guidance, and a peer community for women who have experienced miscarriage or baby loss. The feature activates automatically when...
Dayne Williams, Quantum Health
Quantum Health, a leading employee health navigation firm, appointed Dayne Williams as CEO after Zane Burke retired for personal reasons. Williams returns from retirement to steer the company following recent acquisitions of Embold Health, a doctor‑ranking analytics platform, and CirrusMD,...
AI Chatbots Recommending Chemo Alternatives, Study Warns
A study by the Lundquist Institute evaluated major AI chatbots—including Grok, ChatGPT, Gemini, Meta AI and DeepSeek—on cancer‑treatment queries. Experts rated almost half of the responses as problematic, with 30% deemed somewhat inaccurate and 19.6% highly misleading. The bots often...
Salvador Marino at ACUD Galerie, Berlin
Salvador Marino’s "Iron Stream" installation opened at ACUD Galerie in Berlin, using sci‑fi‑inspired medical devices to interrogate the blood industry’s capitalist underpinnings. The work juxtaposes health benefits of donation with necropolitical questions about whose lives are saved and at what cost. Market...
Viewpoint — Politicization of Public Health: What’s the Impact of the White House Strategy on Children
The article warns that the politicization of public health under the Trump administration, amplified by anti‑vaccine rhetoric from figures like Robert F. Kennedy Jr., is eroding the measles eradication achieved in 2000. Federal vaccine mandates are being rolled back, and...
The Hospital Math Ain't Mathing
U.S. hospitals are confronting a financial squeeze as payments from Medicare and Medicaid fail to keep pace with rising operating costs. In Arkansas, more than 70% of counties have lost birthing hospitals, and rural facilities nationwide are cutting services or...
Divalent siRNA Clinical Trial Is Now Recruiting
A first‑in‑human trial of a divalent PrP‑siRNA (2439‑s4) is now enrolling 15 symptomatic prion disease participants. The FDA‑cleared IND permits a single‑ascending‑dose study, testing 50 mg, 100 mg and 200 mg levels to assess safety and target engagement. The trial includes an optional...
Benzodiazepine Withdrawal Is Mitochondrial Dysfunction
Benzodiazepines, widely prescribed for anxiety and insomnia, act as whole‑body drugs that target mitochondrial receptors, not just brain GABA pathways. Both chronic use and abrupt cessation can trigger mitochondrial dysfunction, linking the drugs to a roughly 60% increase in mortality...
U.S. MILITARY ENDS 72-YEAR MANDATORY FLU SHOT POLICY
On April 20, 2026, the Secretary of War issued a memorandum ending the U.S. military’s 72‑year mandatory influenza‑vaccination policy, making the flu shot voluntary for active‑duty, reserve, and Department of War civilian personnel. The requirement, first introduced in 1945 during...
Compass Therapeutics, Inc. (CMPX) Up 200% Year-on-Year
Compass Therapeutics (CMPX) has delivered a spectacular rally, climbing 237% over the past year and gaining 16% year‑to‑date. Analyst John Newman of Cannaccord Genuity reaffirmed a Buy rating with a $13 price target on April 7. CEO Thomas Schuetz highlighted that the...
VSRF LIVE TONIGHT: Episode 224: Dr. Paul Marik and Dr. Pierre Kory
VSRF Live aired a special episode featuring Dr. Paul Marik and Dr. Pierre Kory, the co‑founders of the former FLCCC, now the Independent Medical Alliance. Both physicians discuss how they were marginalized for promoting off‑label COVID‑19 protocols and outline their current focus—Marik...
Discovery of a Small Molecule HPK1 Inhibitor for Immuno-Oncology
A biotech firm has disclosed a novel small‑molecule inhibitor of hematopoietic progenitor kinase 1 (HPK1) that demonstrates potent immuno‑oncology activity in preclinical models. The compound achieves sub‑micromolar potency, oral bioavailability, and drives up to 70% tumor regression when combined with...
Hidden Surcharge
A recent HumbleDollar post highlights a little‑known Medicare surcharge that can turn a single extra dollar of income into an effective tax rate exceeding 1,000 percent. The surcharge, known as the Income‑Related Monthly Adjustment Amount (IRMAA), kicks in when a...
Surgery or Bracing for Burst Fractures: No Difference?
A multinational AO Spine Knowledge Forum study compared surgical fixation to non‑operative bracing in 93 neurologically intact adults with thoracolumbar burst fractures. Using the trauma‑specific AO Spine PROST outcome measure, both cohorts improved from baseline scores of 34‑40 to around...
Part 2: The Spaces Between
Bright Frontier, a new platform founded by Janis Naeve and Tim Fitzpatrick, maps systemic gaps in kidney and cardiometabolic (CKM) care and proposes four critical "bridges"—signal to decision, decision to action, action to accountability, and accountability to signal. The analysis...
How Commercial Insurers, Self-Insured Employers, PBMs, and Manufacturers Are Turning GLP-1 Pharmacy Benefits Into Active Managed-Access Operating Systems and Where...
Commercial insurers, self‑insured employers and PBMs are overhauling GLP‑1 pharmacy benefits as the class erupts in cost and utilization. KFF data shows 43% of firms with 5,000+ employees now cover GLP‑1s for weight loss, up from 28% a year earlier,...
Strategic Insights: The Last King of Babylon
Babylon Health, founded by Iranian‑born entrepreneur Ali Parsa in 2013, rode a wave of AI‑driven telemedicine hype to a 2021 IPO that valued the company at $4.2 billion. Within two years, mounting regulatory scrutiny, clinician distrust and operational shortfalls forced the...
Better Healthcare Delivered—In SE Alaska It’s All in Black and White
Southeast Alaska Regional Health Consortium (SEARHC) partnered with advertising firm R&R Partners to launch a new campaign that features real SEARHC providers speaking about care delivery. The campaign relies on authentic, black‑and‑white photography to convey the seriousness of healthcare in...
What Does It Take to Scale Cell and Gene Therapies From Discovery to Commercialization
MaxCyte CEO Maher Masoud says scaling cell and gene therapies requires developers to partner with manufacturers that can move seamlessly from R&D to commercial production. Integrated, best‑in‑class platforms eliminate the need for repeated process re‑optimization, enabling consistent, automated manufacturing. Advances...
Do You Risk Stratify Your Patients for Post-Op Opioid Persistence?
A Finnish nationwide registry linked ACDF surgeries to pharmacy records, revealing that 41.9% of patients filled opioid prescriptions and 41.2% filled gabapentinoids before surgery. Post‑operatively, 69.5% of pre‑op opioid users and 70.9% of gabapentinoid users stopped purchasing these drugs, and...
Physician-Owned Hospitals Get a Narrow CMS Opening
The Centers for Medicare & Medicaid Services (CMS) issued a Request for Information (CMS‑1849‑P) asking whether its Innovation Center can waive the ACA’s Section 6001 to let physician‑owned hospitals voluntarily join the Transforming Episode Accountability Model. A 2023 study found these...
Acorys System Gains FDA Clearance for Real-Time 4D Cardiac Mapping
Corify Care’s Acorys system received FDA clearance, offering clinicians a real‑time, four‑chamber view of cardiac electrical activity without the need for CT or MRI scans. The platform merges 3D anatomical modeling with live electrical signals, creating what the company calls...
UnitedHealth Q1 '26 Earnings: Wall Street Is in Love Again
UnitedHealth Group posted Q1 2026 revenue of $111.7 billion and adjusted earnings per share of $7.23, beating the $6.57 consensus by 11%. The company raised its full‑year adjusted EPS guidance to over $18.25 per share and saw its stock jump about 9%...
The $500,000 Drug and the Cost of Modern Medicine
A 70‑year‑old man with no cardiac symptoms was diagnosed with wild‑type transthyretin amyloid cardiomyopathy after a routine coronary calcium scan revealed a score over 600. The diagnosis triggered a cascade of advanced imaging and a biopsy, leading to approval of...
Architecting Life: Authoring the Future of Species with Dr. Adrian Woolfson
Dr. Adrian Woolfson argues that DNA must be treated as a programmable engineering material, enabling the design of living systems from houses to organs. By decoding DNA's generative grammar, humanity could author genomes and potentially rewrite its own code, ushering...
If 80-Year-Olds Improve Just as Much as 50-Year-Olds After Lumbar Fusion, Are You Overestimating Surgical Risk — or Underestimating What...
A new age‑stratified analysis of 1,100 posterior lumbar decompression and fusion patients shows that patients 80 years and older experience mortality, readmission, revision and pain‑relief outcomes comparable to younger cohorts. All age groups improved similarly on ODI and visual analog pain...
Bridging the Gap Between a Chronic Disease Diagnosis and Treatment
Physicians often assume that a chronic disease diagnosis instantly opens the path to treatment, but patients need time to internalize the new identity the diagnosis imposes. Dr. Donald Kushner illustrates this gap through cases where patients hesitated or refused therapy...
CellCarta Eliminates 9-Hours-Per-Week Regulatory Bottleneck with RegASK’s AI-Driven Intelligence Platform
CellCarta, a global contract research organization, partnered with RegASK to overhaul its regulatory intelligence function. By deploying RegASK’s agentic AI platform, the CRO replaced a manual nine‑hour‑per‑week monitoring process with near‑real‑time updates. The new centralized hub automatically captures, validates and...
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
Agenus appointed BAP Pharma as its exclusive global partner to manage early‑access programs for the botensilimab‑balstilimab (BOT+BAL) immunotherapy combo. The collaboration will handle France’s government‑reimbursed Autorisation d’Accès Compassionnel (AAC) pathway and paid named‑patient programs in several other markets. Agenus has...
Charles River Highlights Effectiveness of VCGs in Toxicology
Charles River Laboratories published a retrospective analysis of 20 nonclinical toxicology studies that replaced traditional concurrent control groups with virtual control groups (VCGs). The review found 100% concordance in No Observed Adverse Effect Level (NOAEL) determinations and demonstrated up to...
Star Therapeutics Receives FDA Rare Pediatric Disease and Breakthrough Therapy Designations for VGA039 in Von Willebrand Disease Prophylaxis
Star Therapeutics announced that the FDA has granted both rare pediatric disease and Breakthrough Therapy designations to its lead candidate VGA039, a monoclonal antibody aimed at preventing bleeding in von Willebrand disease (VWD). The designations support the ongoing Phase 3 VIVID‑6 study,...
The AgeTech Collaborative™ From AARP and HLTH Launch Landmark Collaboration to Advance the Future of Aging
HLTH Inc. and AARP’s AgeTech Collaborative have announced a landmark partnership to accelerate aging‑technology startups. The collaboration will feature 20 vetted companies at HLTH 2026 in Las Vegas, giving them exposure to investors, health systems, and industry leaders. Leveraging AARP’s longevity expertise...
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
Simulations Plus announced a funded collaboration with CDMO Lonza and the U.S. FDA to create a mechanistic, predictive framework for amorphous solid dispersion (ASD) oral drugs. The partnership will combine Lonza's advanced in‑vitro dissolution testing with Simulations Plus' GastroPlus and...
1 in 5 US Blood Donors Show Sign of Prediabetes or Diabetes, Study Finds
A new analysis by the American Red Cross of more than 920,000 U.S. blood donors found that one in five exhibits hemoglobin A1C levels indicating prediabetes or diabetes. Roughly 80% of those elevated readings fall in the prediabetes range, while...
LogiPharma Europe: Why Packaging Must Evolve For Patients
In a follow‑up interview with Pharmaceutical Commerce, Richard Harrop of Topa Thermal argues that pharmaceutical packaging must transition from a product‑centric to a patient‑centric model. The rise of cell and gene therapies and radiopharmaceuticals demands smaller, intuitive, temperature‑controlled packs that...
I Wear a Continuous Glucose Monitor. Here's What MOTS-C Did to My Numbers.
The author, a biohacker who monitors glucose continuously, reports that weekly injections of the mitochondrial peptide MOTS‑c consistently drop post‑meal blood sugar by about 20 mg/dL compared with baseline. The effect appears reproducible across multiple CGM recordings while keeping food intake...
Randomization Inside a Medicare Payment Model, It's Really Cool
The CMS Innovation Center’s ACCESS Model launches a ten‑year, national test of outcome‑aligned payments for technology‑enabled chronic care, offering fixed payments of $90 to $420 per beneficiary across four disease tracks. A distinctive feature is the 90:10 randomization of eligible...
Our Friends in the Lab: A Lab Week Tribute
The post celebrates Medical Laboratory Professionals Week (April 19‑25) by highlighting two young lab technologists, Ayla and Hayley, who demonstrated cutting‑edge automation and meticulous neonatal blood‑type workups. Ayla explained how automated microbiology systems and digital plate reading are reshaping pathogen...
IBS News Flash. Anxiety & IBS Have a Reciprocal Relationship
A retrospective cohort study published in Cureus identified a strong two‑way relationship between anxiety and irritable bowel syndrome (IBS). Individuals with anxiety were more likely to develop IBS later, while those with IBS faced more than double the risk of...
When Shared Decision Making Gives Way to Medical Paternalism
The article highlights how the ideal of shared decision making is increasingly supplanted by medical paternalism, illustrated by a family's struggle to secure a feeding tube for a father with advanced dementia. Physicians sometimes refuse procedures they deem clinically futile,...
NIPT in 2026: How AI and Next-Gen Sequencing Are Changing Prenatal Screening
Non‑invasive prenatal testing (NIPT) in the UK is being reshaped by next‑generation sequencing and artificial‑intelligence algorithms. AI‑driven analysis lifts the positive predictive value for trisomies to roughly 88%, while proprietary enrichment steps like Focus Plus increase fetal DNA fractions 3.6‑fold, slashing...
The AI Drug Discovery Capital Stack in 2026: Who Has Raised the Most, Why Their Technical Approaches Actually Differ, and...
The essay maps AI‑driven drug‑discovery firms’ capital stacks as of April 2026, highlighting that Eikon, Xaira, Isomorphic Labs and Recursion sit at the top of disclosed funding. It separates the sector into four technical lanes—structure foundation models, generative chemistry, phenomics/perturbational biology,...
Quadricuspid Aortic Valve: The Diagnosis Hiding in Your Short-Axis View
The article highlights the quadricuspid aortic valve, a rare congenital anomaly often mistaken for a bicuspid valve. Because sonographers rarely look for four cusps, the condition is mislabelled, allowing aortic regurgitation to progress unchecked. By focusing on the short‑axis echocardiographic...
They Called Me a “Maverick”
Dr. Gator, author of "Between a Shot and Hard Place," was profiled in The MAHA Report, where his stance on vaccine informed consent was examined. The article explores the widening gap between parents and the medical community, emphasizing the need...
Please Don’t Trust Your Chatbot for Medical Advice
Recent peer‑reviewed studies across BMJ, JAMA Network Open, and Nature Medicine reveal that popular AI chatbots—including ChatGPT, Gemini, and Meta AI—frequently generate inaccurate, hallucinated, or overconfident medical advice. The BMJ audit found nearly half of responses were highly problematic, while...
MyChart Unpacked
The author performed a static inspection of Epic’s MyChart Android application package, uncovering roughly 250 custom deep‑link URLs that route users directly to specific screens. By decompiling the APK, the analysis reveals a richer feature set than the typical web‑based...
The Reality of PrEP Access and HIV Prevention in Georgia
Georgia holds the nation’s second‑highest rate of new HIV diagnoses, prompting lawmakers to pass a bill that authorizes pharmacists to prescribe PrEP without a physician visit. While the measure could streamline access, the article highlights that half a million Georgians...